Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
relacatib cathepsin k small molecule Clinical trial target TTD , drugbank , DGIDB Bone Tissue[MeSHID:D001842]
Osteoporosis[MeSHID:D010024]
Neoplasm Metastasis[MeSHID:D009362]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 25.46 investigational,discontinued in phase 2 unknown
relacatib cathepsin k small molecule Clinical trial target TTD , drugbank , DGIDB Bone Tissue[MeSHID:D001842]
Osteoporosis[MeSHID:D010024]
Neoplasm Metastasis[MeSHID:D009362]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 25.46 investigational,discontinued in phase 2 inhibitor
relacatib cathepsin k small molecule Clinical trial target TTD , drugbank , DGIDB Bone Tissue[MeSHID:D001842]
Osteoporosis[MeSHID:D010024]
Neoplasm Metastasis[MeSHID:D009362]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 25.46 investigational,discontinued in phase 2 inhibitor
relacatib cathepsin k small molecule Clinical trial target TTD , drugbank , DGIDB Bone Tissue[MeSHID:D001842]
Osteoporosis[MeSHID:D010024]
Neoplasm Metastasis[MeSHID:D009362]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 25.46 investigational,discontinued in phase 2 unknown
click here to return to the previous page